Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG

Approved

STANDARD

ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG

Viatris Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 24, 2024
Approval ID: 9a61f4794122368d
Company: Viatris Limited
Type: Standard

Approval Details

Approval Id: 9a61f4794122368d
Drug Cima Aemps Name: ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG
Register Number: 89659
Holder Company Name: Viatris Limited
Marketing Company Name: Viatris Pharmaceuticals S.L.
Holder Company Detail Path: /organization/viatris-pharma-limited
Authorization Date: 2024-06-24
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 0,44 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Viatris Limited
Company Detail Path: /organization/viatris-pharma-limited

Company Information

Pharmaceutical Company Name: VIATRIS PHARMA LIMITED
Country Name: Hong Kong, China
City Name: sha tin,country_hk
Address: Rm A7 8/F WAH WAI INDL BLDG

Active Ingredients

ERIBULINA

0,88 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 24, 2024

Approval ID

9a61f4794122368d

Type

Standard

Back to CIMA-AEMPS Approvals